Outlook Therapeutics

Outlook Therapeutics

A late clinical-stage biopharmaceutical company.

HQ location
Cranbury Township, United States
Launch date
Employees
Market cap
$71.1m
Enterprise value
$97m
Share price
$1.60 OTLK
Authorizing premium user...